Doozio Posted - 1 week ago

$LMAT it’s only obvious when it’s obvious like wen it’s INTA 🧠⏰♾️. Obviously

jeffmeredith Posted - 2 weeks ago

$LMAT 9/17 $90.27s sold at $102.98 = 14.1% gain in 50 days ... $103.96 ath

jeffmeredith Posted - 2 weeks ago

$LMAT We have a runner on an earnings beat, $101.67 ath

Doozio Posted - 2 weeks ago

$LMAT wen da FUTUre of 🧠⏰ is NOW during 🧠⏰♾️

MaverikIT Posted - 2 weeks ago

@IsabellaDC @net0trader $LMAT +9.05 - keeping da heart beating

jeffmeredith Posted - 2 weeks ago

$LMAT $99.91 ath

nvdamoney Posted - 10/28/24

$LMAT interested

Estimize Posted - 10/28/24

$LMAT analysts on Estimize are expecting 13.50% YoY revenue growth for Q3, down from 14.22% in Q2 [Reporting 10/31 AMC] http://www.estimize

contrariantrade Posted - 1 month ago

Is This the End of the Bull Market? 6pm EST Sunday $VLY $FLG $VRRM $LMAT $XPO https://youtube.com/live/gu9zWDAtKg0?feature=share

DiamondCapital Posted - 1 month ago

$ADHC is one to take serious. Recently completed acquisition GlucoGuard which Bill Colone is actually listed as the Chairman of the Board. https://x.com/stockpicksnyc/status/1843276958513107435?s=46 The past companies he was involved in: •IMPRA Inc acquired by CR Bard for $143M •Endomed acquired by $LMAT LeMaitre Vascular •Bill Colone is also the current CEO of SinglePass which recently got FDA clearance in April for their Kronos biopsy closure device. He’s listed as the Chairman of GlucoGuard here: glucoguardsleep.com/about-us/

DiamondCapital Posted - 2 months ago

$ADHC Bill Colone also helped position a surgical vascular graft product company IMPRA Inc which later was ACQUIRED by CR Bard for $143M Bill was Director of Operations of IMPRA for 11 years. Also Bill was the active CEO of Endomed when it was ACQUIRED by $LMAT LeMaitre Vascular. See here: https://x.com/stockpicksnyc/status/1831685132069302744?s=46 Bill Colone is also the current CEO of SinglePass which recently got FDA clearance in April for their Kronos biopsy closure device. Upon joining ADHC Bill Colone stated: “I look forward to working with the ADHC team to target opportunities in the bio device space. Bringing shareholder value to ADHC through an acquisition or strategic alliance is the primary goal. The ADHC public vehicle presents compelling…” commented Mr. Colone in this press release here: https://www.newsfilecorp.com/release/211813/American-Diversified-Holdings-Corporation-ADHC-Retains-Bio-Device-Veteran-Bill-Colone-to-Advise-on-Entering-585-Billion-Bio-Device-Arena

windough Posted - 08/28/24

$LMAT $ADHC Oh I see you did disclose......$ADHC is utter trash and you are foolish to risk your cred on this

windough Posted - 08/28/24

$LMAT $ADHC You are paid for this.....BEWARE, eyes are on you for not disclosing

DiamondCapital Posted - 08/28/24

$ADHC is only getting started. Bill Colone joined $ADHC recently in June of this year. He’s Nasdaq caliber. See here: https://x.com/stockpicksnyc/status/1828785781432889519?s=46 Colone sold his first startup Endomed to LeMaitre Vascular $LMAT a giant $2B MC company He’s also the current CEO of SinglePass which recently got FDA clearance in April for their Kronos biopsy closure device. Upon joining ADHC he stated: “I look forward to working with the ADHC team to target opportunities in the bio device space. Bringing shareholder value to ADHC through an acquisition or strategic alliance is the primary goal. The ADHC public vehicle presents compelling opportunities for private bio device companies looking to grow and gain exposure,” commented Mr. Colone in this press release here: https://www.newsfilecorp.com/release/211813/American-Diversified-Holdings-Corporation-ADHC-Retains-Bio-Device-Veteran-Bill-Colone-to-Advise-on-Entering-585-Billion-Bio-Device-Arena

DiamondCapital Posted - 3 months ago

$ADHC beautiful day! Worth noting Bill’s track record. Hes the current CEO of SinglePass, which recently got FDA clearance for their medical device Bill Colone was also the CEO and co-founder of Endomed, which was acquired by LeMaitre Vascular $LMAT Now hes working on $ADHC and officially on the team! DD thread here: https://x.com/stockpicksnyc/status/1825995600271204810?s=46 Bill actually navigated numerous companies through the FDA Approval process In a PR, Bill stated "I look forward to working with the ADHC team to target opportunities in the bio device space. Bringing shareholder value to ADHC through an acquisition or strategic alliance is the primary goal. The ADHC public vehicle presents compelling opportunities for private bio device companies looking to grow and gain exposure," commented Bill Colone See here: https://finance.yahoo.com/news/american-diversified-holdings-corporation-adhc-100000888.html

DiamondCapital Posted - 3 months ago

$ADHC Bill Colone heavily involved, check his statements from past 2 press releases. He’s helping with AI division and also acquisitions in Bio Device space He has an serious track record, see the attached tweet. SinglePass FDA approval and his past company bought out by $LMAT plus more.. See here: https://x.com/stockpicksnyc/status/1825522053560033412?s=46

insiderbuyingselling Posted - 3 months ago

$LMAT new insider selling: 3063 shares. http://insiderbuyingselling.com/?t=LMAT

DiamondCapital Posted - 3 months ago

Watch these plays right now🔥 $ABQQ commented on the RS today Potential $ASII type move ahead once official announcement/8-K $AHRO MAJOR partnership with ZEASN/WhaleEcho $ADHC Fresh AI play with solid team including Bill Colone former CEO of Endomed acquired by $LMAT LeMaitre Vascular and he’s the current the CEO of SinglePass, which recently got FDA clearance for their medical device. https://x.com/stockpicksnyc/status/1823787706243019012?s=46

windough Posted - 3 months ago

$ADHC $LMAT all BS

DiamondCapital Posted - 3 months ago

Bill Colone recently joined $ADHC board of advisors in June. He’s the CEO of SinglePass, which recently got FDA clearance for their medical device Bill Colone was also the CEO and co-founder of Endomed, which was acquired by LeMaitre Vascular $LMAT https://x.com/stockpicksnyc/status/1823714815493255316?s=46 He has a serious track record. Bill Colone formerly served as the CEO at Spinal Singularity, and as the VP of R&D for Direct Flow Medical. He also served as Director of Research and Development, and later Director of Aortic Procedure Development, for Endologix. Mr. Colone directed the development of the Nellix Endovascular Aneurysm Sealing System through design completion, CE trial completion, CE Mark approval, and OUS commercial launch. He also contributed to the procedure development and training for the US IDE investigation centers leading to the fastest enrolled IDE trial for an EVAR device.

StockInvest_us Posted - 3 months ago

Signal alert: $LMAT - PivotPoint bottom https://stockinvest.us/l/RcdVTHZFLC

UncleStock Posted - 3 months ago

$OSUR $UTMD $RMD $LMAT suggested for Health Care Equipment & Services - value screen: https://zpr.io/HyH9V

Doozio Posted - 3 months ago

$LMAT too many 🐑 bahhht FOUR weeks tight so wen 🧠⏰?

Estimize Posted - 3 months ago

$LMAT beats the Estimize EPS Consensus by 3c and the Estimize Revenue Consensus by $0.56M. Reports FQ2 earnings of 52c EPS and $55.85M ... http://www.estimize.com/lmat/fq2-2024?utm_content=beat_or_miss&utm_medium=tweet&utm_source=stocktwits

Stock_Titan Posted - 3 months ago

$LMAT LeMaitre Q2 2024 Financial Results https://www.stocktitan.net/news/LMAT/le-maitre-q2-2024-financial-fvnsnix2w0ps.html

Estimize Posted - 3 months ago

$LMAT reports after the close, Estimize Consensus +0.02 EPS and +0.31M Revs compared to WS http://www.estimize.com/lmat/fq2-2024?utm_content=prerelease&utm_medium=tweet&utm_source=stocktwits

NVDAMillionaire Posted - 07/31/24

$LMAT LeMaitre Vascular, Inc. (NASDAQ:LMAT): A Diversified Medical Device Manufacturer Delivering Consistent Growth http://beyondspx.com/2024/07/31/lemaitre-vascular-inc-nasdaqlmat-a-diversified-medical-device-manufacturer-delivering-consistent-growth/

insiderbuyingselling Posted - 4 months ago

$LMAT new insider selling: 57372 shares. http://insiderbuyingselling.com/?t=LMAT

Stock_Titan Posted - 4 months ago

$LMAT LeMaitre Will Announce Second Quarter 2024 Earnings Results August 1, 2024 https://www.stocktitan.net/news/LMAT/le-maitre-will-announce-second-quarter-2024-earnings-results-august-t579t9hr4upm.html

InsiderPeek Posted - 4 months ago

$LMAT CEO Lemaitre George W sold 40k shares for $3.4 millions (ownership down 2.0%) insiderpeek.com/company/LMAT